RICHMOND, British Columbia, Sept. 18, 2007 (PRIME NEWSWIRE) -- BioCurex, Inc. (OTCBB:BOCX) announced today a presentation to the International Society for Oncodevelopmental Biology and Medicine (ISOBM). The presentation documents a study conducted by BioCurex in its development of a ‘rapid test’ for ambulatory cancer detection, based on its patented RECAF(tm) cancer marker. This study was conducted in conjunction with the Blokhin Cancer Research Centre, Moscow, Russia.
